Treatment of Viral Meningitis Due to Seasonal Flu
For viral meningitis caused by seasonal influenza, treatment is primarily supportive care, as there is no specific antiviral therapy proven effective for influenza-associated meningitis; however, oseltamivir (75 mg twice daily for 5 days in adults) should be administered if the patient presents within 48 hours of symptom onset, particularly in hospitalized patients or those at high risk for complications.
Key Treatment Principles
Antiviral Therapy Considerations
While neuraminidase inhibitors like oseltamivir are effective for uncomplicated influenza respiratory illness, their efficacy specifically for influenza-associated meningitis or encephalitis has not been established in controlled trials 1, 2. The evidence for antiviral use comes from studies of uncomplicated influenza, not CNS complications 3, 4.
Despite this limitation, oseltamivir should still be administered because:
- Hospitalized patients with presumed influenza warrant treatment regardless of time from symptom onset 1, 2
- Early treatment (within 48 hours) reduces duration of illness and complications in general influenza cases 3, 4
- There are no alternative proven pharmacological interventions for influenza-associated CNS disease
Dosing Recommendations
Adults: 75 mg orally twice daily for 5 days 5, 1
Children (weight-based):
- ≤15 kg: 30 mg twice daily
15-23 kg: 45 mg twice daily
23-40 kg: 60 mg twice daily
40 kg: 75 mg twice daily 5
Infants:
- 9-11 months: 3.5 mg/kg twice daily
- 0-8 months (term): 3 mg/kg twice daily 5
Supportive Care is Primary
The mainstay of treatment for viral meningitis is supportive management 6, 7:
- Hospitalization for monitoring and symptom management
- Intravenous fluids for hydration
- Antipyretics for fever control
- Analgesia for headache
- Seizure management if needed
- Monitoring for complications (cerebral edema, increased intracranial pressure)
Critical Diagnostic Steps
Lumbar puncture should be performed unless contraindicated 6, 7:
- Obtain opening pressure, cell count, glucose, protein
- PCR testing for influenza virus in CSF (though sensitivity may be limited)
- Rule out bacterial meningitis requiring different treatment
Head CT before LP if: GCS ≤9 or falling, seizures, focal neurological signs, or papilloedema 7
Important Caveats
Do NOT use corticosteroids routinely - Unlike bacterial meningitis where dexamethasone is beneficial 8, there is no convincing evidence for immunosuppressive treatment in viral encephalitis or meningitis 6, 8. One RCT showed no clear benefit of corticosteroids in viral encephalitis 8.
Consider bacterial co-infection - Secondary bacterial infections occur in 20-38% of severe influenza cases 2. If bacterial meningitis cannot be excluded, add empiric antibacterial coverage (third-generation cephalosporin at meningitis dosing plus acyclovir) until bacterial causes are ruled out 7.
Longer treatment courses may be considered - While standard treatment is 5 days, some experts suggest 10 days or treatment until symptom resolution in immunocompromised patients, though this remains controversial 9.
Prognosis and Monitoring
Influenza-associated meningitis/encephalitis carries significant morbidity - approximately 40% of CNS infection survivors have permanent disability 7. Close monitoring for complications including cerebral edema, ischemia, and ventriculitis is essential, as over half of ICU patients develop intracranial complications 7.
The case report 10 illustrates that focal encephalitis with meningitis can occur with influenza A and responds to oseltamivir plus supportive care, reinforcing the treatment approach outlined above.